Celeste C Finnerty Selected Research

Oxandrolone (Anavar)

1/2018	Reduced Postburn Hypertrophic Scarring and Improved Physical Recovery With Yearlong Administration of Oxandrolone and Propranolol.
7/2017	Oxandrolone Coadministration Does Not Alter Plasma Propranolol Concentrations in Severely Burned Pediatric Patients.
9/2016	Long-Term Administration of Oxandrolone Improves Lung Function in Pediatric Burned Patients.
9/2016	Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children.
4/2016	FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN: A RANDOMIZED CLINICAL TRIAL.
4/2012	Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy.
11/2008	Impact of oxandrolone treatment on acute outcomes after severe burn injury.
9/2007	The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.
9/2005	Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Celeste C Finnerty Research Topics

Disease

94	Burns 01/2020 - 09/2005
19	Wounds and Injuries (Trauma) 01/2020 - 08/2005
17	Infections 12/2017 - 07/2006
16	Sepsis (Septicemia) 01/2018 - 07/2006
13	Inflammation (Inflammations) 01/2020 - 01/2007
9	Insulin Resistance 09/2014 - 09/2007
8	Acute-Phase Reaction 03/2015 - 09/2007
7	Cicatrix (Scar) 01/2020 - 03/2012
7	Critical Illness (Critically Ill) 12/2018 - 09/2007
5	Body Weight (Weight, Body) 01/2018 - 09/2005
4	Hyperglycemia 06/2012 - 03/2008
3	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2018 - 03/2012
3	Multiple Organ Failure (MODS) 05/2014 - 07/2009
3	Wound Infection (Wound Infections) 01/2012 - 02/2007
2	Fibrosis (Cirrhosis) 01/2020 - 12/2017
2	Pain (Aches) 12/2018 - 01/2018
2	Pneumonia (Pneumonitis) 11/2015 - 05/2014
2	Edema (Dropsy) 05/2015 - 09/2007

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 01/2020 - 07/2006
18	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
13	Propranolol (Inderal)FDA LinkGeneric 01/2018 - 03/2007
12	Insulin (Novolin)FDA Link 09/2014 - 09/2005
10	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2007
10	Glucose (Dextrose)FDA LinkGeneric 09/2019 - 08/2010
9	Oxandrolone (Anavar)FDA LinkGeneric 01/2018 - 09/2005
8	Biomarkers (Surrogate Marker)IBA 09/2019 - 09/2010
7	Hormones (Hormone)IBA 01/2016 - 05/2007
5	CatecholaminesIBA 01/2018 - 01/2011
5	Interleukin-8 (Interleukin 8)IBA 03/2015 - 01/2007
5	Interleukin-10 (Interleukin 10)IBA 12/2014 - 01/2007
4	EnzymesIBA 01/2020 - 07/2011
4	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2009
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2015 - 08/2010
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2012 - 09/2005
4	Muscle Proteins (Muscle Protein)IBA 01/2012 - 01/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2007
3	CollagenIBA 01/2020 - 03/2012
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018 - 01/2016
3	LipidsIBA 01/2018 - 01/2013
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 08/2009
3	CalciumIBA 12/2015 - 08/2009
2	Edetic Acid (EDTA)FDA Link 01/2020 - 12/2015
2	MetalsIBA 01/2020 - 12/2015
2	brassIBA 01/2020 - 12/2015
2	Chelating AgentsIBA 01/2020 - 12/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2017 - 01/2009
2	CreatinineIBA 12/2017 - 01/2016
2	Vancomycin FDA LinkGeneric 12/2017 - 04/2016
2	Antiviral Agents (Antivirals)IBA 08/2017 - 02/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 03/2012
2	Oxygen (Dioxygen)IBA 11/2016 - 01/2008
2	Peptides (Polypeptides)IBA 01/2016 - 01/2013
2	Caspase 3 (Caspase-3)IBA 01/2016 - 09/2009
2	IronIBA 01/2016 - 12/2015
2	Blood Glucose (Blood Sugar)IBA 05/2014 - 04/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 05/2014 - 06/2012
2	Anabolic AgentsIBA 04/2014 - 12/2012
2	Complement System Proteins (Complement)IBA 06/2013 - 09/2010
2	ProteomeIBA 06/2013 - 09/2010
2	Blood Proteins (Serum Proteins)IBA 06/2012 - 09/2010
2	Insulin ReceptorIBA 05/2012 - 02/2012
2	Growth Hormone (Somatotropin)IBA 10/2011 - 08/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 10/2011 - 09/2005
2	IsotopesIBA 08/2011 - 05/2009
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2009 - 07/2006
2	Interleukin-17 (Interleukin 17)IBA 01/2009 - 09/2008
2	Interleukin-4 (Interleukin 4)IBA 09/2008 - 01/2008
2	Interleukin-5 (Interleukin 5)IBA 09/2008 - 02/2007
2	Interleukin-7 (Interleukin 7)IBA 09/2008 - 01/2008
2	Interleukin-12 (IL 12)IBA 09/2008 - 01/2007
2	Human Growth Hormone (Saizen)FDA LinkGeneric 03/2008 - 09/2005
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	MyostatinIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	OsteocalcinIBA 09/2019
1	Ethanolamine (Colamine)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 12/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 12/2018
1	Hemoglobins (Hemoglobin)IBA 12/2018
1	FibrinIBA 01/2018
1	AcidsIBA 01/2018
1	poly(lactide- co- trimethylenecarbonate- co- epsilon- caprolactone)IBA 01/2018
1	N 30IBA 01/2018

Therapy/Procedure

11	Therapeutics 01/2020 - 03/2008
9	Length of Stay 01/2018 - 02/2007
7	Critical Care (Surgical Intensive Care) 01/2017 - 02/2007
4	Resuscitation 12/2016 - 01/2009
3	Artificial Skin 12/2017 - 01/2015
2	Blood Transfusion (Blood Transfusions) 12/2018 - 02/2007
2	Glycemic Control 01/2016 - 08/2010
2	Mechanical Ventilators (Ventilator) 11/2015 - 01/2008
2	Operative Surgical Procedures 01/2015 - 04/2014
1	Emergency Treatment 01/2020
1	Anesthesia and Analgesia 12/2018
1	Vascular Access Devices (Arterial Line) 11/2018